nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—Hyperuricaemia—Cisplatin—bone cancer	0.0268	0.0268	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Cisplatin—bone cancer	0.0253	0.0253	CcSEcCtD
Methyclothiazide—Body temperature increased—Carboplatin—bone cancer	0.0239	0.0239	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Cisplatin—bone cancer	0.02	0.02	CcSEcCtD
Methyclothiazide—Hypercalcaemia—Epirubicin—bone cancer	0.0184	0.0184	CcSEcCtD
Methyclothiazide—Hypercalcaemia—Doxorubicin—bone cancer	0.017	0.017	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Cisplatin—bone cancer	0.0165	0.0165	CcSEcCtD
Methyclothiazide—Cramp muscle—Cisplatin—bone cancer	0.0162	0.0162	CcSEcCtD
Methyclothiazide—Glycosuria—Epirubicin—bone cancer	0.0157	0.0157	CcSEcCtD
Methyclothiazide—Pancreatitis—Cisplatin—bone cancer	0.0153	0.0153	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Methotrexate—bone cancer	0.0147	0.0147	CcSEcCtD
Methyclothiazide—Glycosuria—Doxorubicin—bone cancer	0.0146	0.0146	CcSEcCtD
Methyclothiazide—Vasculitis—Methotrexate—bone cancer	0.014	0.014	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Methotrexate—bone cancer	0.0139	0.0139	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Epirubicin—bone cancer	0.0137	0.0137	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Epirubicin—bone cancer	0.013	0.013	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Methotrexate—bone cancer	0.0128	0.0128	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Doxorubicin—bone cancer	0.0127	0.0127	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Methotrexate—bone cancer	0.0121	0.0121	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Doxorubicin—bone cancer	0.012	0.012	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Epirubicin—bone cancer	0.012	0.012	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Epirubicin—bone cancer	0.0114	0.0114	CcSEcCtD
Methyclothiazide—Photosensitivity—Methotrexate—bone cancer	0.0113	0.0113	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Doxorubicin—bone cancer	0.0111	0.0111	CcSEcCtD
Methyclothiazide—Malnutrition—Cisplatin—bone cancer	0.0109	0.0109	CcSEcCtD
Methyclothiazide—Photosensitivity—Epirubicin—bone cancer	0.0105	0.0105	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Doxorubicin—bone cancer	0.0105	0.0105	CcSEcCtD
Methyclothiazide—Muscle spasms—Cisplatin—bone cancer	0.0104	0.0104	CcSEcCtD
Methyclothiazide—Vascular purpura—Epirubicin—bone cancer	0.0103	0.0103	CcSEcCtD
Methyclothiazide—Vision blurred—Cisplatin—bone cancer	0.0102	0.0102	CcSEcCtD
Methyclothiazide—Photosensitivity—Doxorubicin—bone cancer	0.00975	0.00975	CcSEcCtD
Methyclothiazide—Leukopenia—Cisplatin—bone cancer	0.00972	0.00972	CcSEcCtD
Methyclothiazide—Purpura—Epirubicin—bone cancer	0.0096	0.0096	CcSEcCtD
Methyclothiazide—Vascular purpura—Doxorubicin—bone cancer	0.00957	0.00957	CcSEcCtD
Methyclothiazide—Purpura—Doxorubicin—bone cancer	0.00889	0.00889	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Cisplatin—bone cancer	0.00886	0.00886	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Cisplatin—bone cancer	0.00867	0.00867	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Epirubicin—bone cancer	0.00845	0.00845	CcSEcCtD
Methyclothiazide—Anorexia—Cisplatin—bone cancer	0.00844	0.00844	CcSEcCtD
Methyclothiazide—Pancreatitis—Methotrexate—bone cancer	0.00838	0.00838	CcSEcCtD
Methyclothiazide—Paraesthesia—Cisplatin—bone cancer	0.00796	0.00796	CcSEcCtD
Methyclothiazide—Pancreatitis—Epirubicin—bone cancer	0.00784	0.00784	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Doxorubicin—bone cancer	0.00782	0.00782	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Methotrexate—bone cancer	0.0078	0.0078	CcSEcCtD
Methyclothiazide—Decreased appetite—Cisplatin—bone cancer	0.0077	0.0077	CcSEcCtD
Methyclothiazide—Pneumonia—Methotrexate—bone cancer	0.00767	0.00767	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00756	0.00756	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Epirubicin—bone cancer	0.0073	0.0073	CcSEcCtD
Methyclothiazide—Pancreatitis—Doxorubicin—bone cancer	0.00726	0.00726	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Epirubicin—bone cancer	0.00722	0.00722	CcSEcCtD
Methyclothiazide—Pneumonia—Epirubicin—bone cancer	0.00717	0.00717	CcSEcCtD
Methyclothiazide—Agranulocytosis—Methotrexate—bone cancer	0.00711	0.00711	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00707	0.00707	CcSEcCtD
Methyclothiazide—Body temperature increased—Cisplatin—bone cancer	0.007	0.007	CcSEcCtD
Methyclothiazide—Jaundice—Epirubicin—bone cancer	0.00695	0.00695	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Doxorubicin—bone cancer	0.00676	0.00676	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Doxorubicin—bone cancer	0.00668	0.00668	CcSEcCtD
Methyclothiazide—Agranulocytosis—Epirubicin—bone cancer	0.00666	0.00666	CcSEcCtD
Methyclothiazide—Pneumonia—Doxorubicin—bone cancer	0.00664	0.00664	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00654	0.00654	CcSEcCtD
Methyclothiazide—Hypersensitivity—Cisplatin—bone cancer	0.00653	0.00653	CcSEcCtD
Methyclothiazide—Erythema multiforme—Methotrexate—bone cancer	0.00647	0.00647	CcSEcCtD
Methyclothiazide—Jaundice—Doxorubicin—bone cancer	0.00643	0.00643	CcSEcCtD
Methyclothiazide—Asthenia—Cisplatin—bone cancer	0.00636	0.00636	CcSEcCtD
Methyclothiazide—Agranulocytosis—Doxorubicin—bone cancer	0.00616	0.00616	CcSEcCtD
Methyclothiazide—Diarrhoea—Cisplatin—bone cancer	0.00606	0.00606	CcSEcCtD
Methyclothiazide—Erythema multiforme—Epirubicin—bone cancer	0.00605	0.00605	CcSEcCtD
Methyclothiazide—Malnutrition—Methotrexate—bone cancer	0.00596	0.00596	CcSEcCtD
Methyclothiazide—Vomiting—Cisplatin—bone cancer	0.00563	0.00563	CcSEcCtD
Methyclothiazide—Vision blurred—Methotrexate—bone cancer	0.00561	0.00561	CcSEcCtD
Methyclothiazide—Erythema multiforme—Doxorubicin—bone cancer	0.0056	0.0056	CcSEcCtD
Methyclothiazide—Rash—Cisplatin—bone cancer	0.00559	0.00559	CcSEcCtD
Methyclothiazide—Dermatitis—Cisplatin—bone cancer	0.00558	0.00558	CcSEcCtD
Methyclothiazide—Malnutrition—Epirubicin—bone cancer	0.00557	0.00557	CcSEcCtD
Methyclothiazide—Muscle spasms—Epirubicin—bone cancer	0.00536	0.00536	CcSEcCtD
Methyclothiazide—Vertigo—Methotrexate—bone cancer	0.00535	0.00535	CcSEcCtD
Methyclothiazide—Leukopenia—Methotrexate—bone cancer	0.00533	0.00533	CcSEcCtD
Methyclothiazide—Nausea—Cisplatin—bone cancer	0.00526	0.00526	CcSEcCtD
Methyclothiazide—Vision blurred—Epirubicin—bone cancer	0.00525	0.00525	CcSEcCtD
Methyclothiazide—Malnutrition—Doxorubicin—bone cancer	0.00516	0.00516	CcSEcCtD
Methyclothiazide—Agitation—Epirubicin—bone cancer	0.00512	0.00512	CcSEcCtD
Methyclothiazide—Vertigo—Epirubicin—bone cancer	0.00501	0.00501	CcSEcCtD
Methyclothiazide—Leukopenia—Epirubicin—bone cancer	0.00499	0.00499	CcSEcCtD
Methyclothiazide—Muscle spasms—Doxorubicin—bone cancer	0.00496	0.00496	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Methotrexate—bone cancer	0.00486	0.00486	CcSEcCtD
Methyclothiazide—Vision blurred—Doxorubicin—bone cancer	0.00486	0.00486	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Methotrexate—bone cancer	0.00476	0.00476	CcSEcCtD
Methyclothiazide—Agitation—Doxorubicin—bone cancer	0.00474	0.00474	CcSEcCtD
Methyclothiazide—Vertigo—Doxorubicin—bone cancer	0.00463	0.00463	CcSEcCtD
Methyclothiazide—Anorexia—Methotrexate—bone cancer	0.00463	0.00463	CcSEcCtD
Methyclothiazide—Leukopenia—Doxorubicin—bone cancer	0.00462	0.00462	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Epirubicin—bone cancer	0.00455	0.00455	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Epirubicin—bone cancer	0.00445	0.00445	CcSEcCtD
Methyclothiazide—Paraesthesia—Methotrexate—bone cancer	0.00437	0.00437	CcSEcCtD
Methyclothiazide—Anorexia—Epirubicin—bone cancer	0.00434	0.00434	CcSEcCtD
Methyclothiazide—Decreased appetite—Methotrexate—bone cancer	0.00423	0.00423	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Doxorubicin—bone cancer	0.00421	0.00421	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Doxorubicin—bone cancer	0.00412	0.00412	CcSEcCtD
Methyclothiazide—Paraesthesia—Epirubicin—bone cancer	0.00409	0.00409	CcSEcCtD
Methyclothiazide—Anorexia—Doxorubicin—bone cancer	0.00401	0.00401	CcSEcCtD
Methyclothiazide—Decreased appetite—Epirubicin—bone cancer	0.00395	0.00395	CcSEcCtD
Methyclothiazide—Constipation—Epirubicin—bone cancer	0.00389	0.00389	CcSEcCtD
Methyclothiazide—Urticaria—Methotrexate—bone cancer	0.00386	0.00386	CcSEcCtD
Methyclothiazide—Body temperature increased—Methotrexate—bone cancer	0.00384	0.00384	CcSEcCtD
Methyclothiazide—Paraesthesia—Doxorubicin—bone cancer	0.00378	0.00378	CcSEcCtD
Methyclothiazide—Decreased appetite—Doxorubicin—bone cancer	0.00366	0.00366	CcSEcCtD
Methyclothiazide—Urticaria—Epirubicin—bone cancer	0.00361	0.00361	CcSEcCtD
Methyclothiazide—Constipation—Doxorubicin—bone cancer	0.0036	0.0036	CcSEcCtD
Methyclothiazide—Body temperature increased—Epirubicin—bone cancer	0.0036	0.0036	CcSEcCtD
Methyclothiazide—Hypersensitivity—Methotrexate—bone cancer	0.00358	0.00358	CcSEcCtD
Methyclothiazide—Asthenia—Methotrexate—bone cancer	0.00349	0.00349	CcSEcCtD
Methyclothiazide—Hypersensitivity—Epirubicin—bone cancer	0.00335	0.00335	CcSEcCtD
Methyclothiazide—Urticaria—Doxorubicin—bone cancer	0.00334	0.00334	CcSEcCtD
Methyclothiazide—Body temperature increased—Doxorubicin—bone cancer	0.00333	0.00333	CcSEcCtD
Methyclothiazide—Diarrhoea—Methotrexate—bone cancer	0.00333	0.00333	CcSEcCtD
Methyclothiazide—Asthenia—Epirubicin—bone cancer	0.00326	0.00326	CcSEcCtD
Methyclothiazide—Dizziness—Methotrexate—bone cancer	0.00321	0.00321	CcSEcCtD
Methyclothiazide—Diarrhoea—Epirubicin—bone cancer	0.00311	0.00311	CcSEcCtD
Methyclothiazide—Hypersensitivity—Doxorubicin—bone cancer	0.0031	0.0031	CcSEcCtD
Methyclothiazide—Vomiting—Methotrexate—bone cancer	0.00309	0.00309	CcSEcCtD
Methyclothiazide—Rash—Methotrexate—bone cancer	0.00307	0.00307	CcSEcCtD
Methyclothiazide—Dermatitis—Methotrexate—bone cancer	0.00306	0.00306	CcSEcCtD
Methyclothiazide—Headache—Methotrexate—bone cancer	0.00305	0.00305	CcSEcCtD
Methyclothiazide—Asthenia—Doxorubicin—bone cancer	0.00302	0.00302	CcSEcCtD
Methyclothiazide—Dizziness—Epirubicin—bone cancer	0.00301	0.00301	CcSEcCtD
Methyclothiazide—Vomiting—Epirubicin—bone cancer	0.00289	0.00289	CcSEcCtD
Methyclothiazide—Nausea—Methotrexate—bone cancer	0.00289	0.00289	CcSEcCtD
Methyclothiazide—Diarrhoea—Doxorubicin—bone cancer	0.00288	0.00288	CcSEcCtD
Methyclothiazide—Rash—Epirubicin—bone cancer	0.00287	0.00287	CcSEcCtD
Methyclothiazide—Dermatitis—Epirubicin—bone cancer	0.00287	0.00287	CcSEcCtD
Methyclothiazide—Headache—Epirubicin—bone cancer	0.00285	0.00285	CcSEcCtD
Methyclothiazide—Dizziness—Doxorubicin—bone cancer	0.00278	0.00278	CcSEcCtD
Methyclothiazide—Nausea—Epirubicin—bone cancer	0.0027	0.0027	CcSEcCtD
Methyclothiazide—Vomiting—Doxorubicin—bone cancer	0.00268	0.00268	CcSEcCtD
Methyclothiazide—Rash—Doxorubicin—bone cancer	0.00265	0.00265	CcSEcCtD
Methyclothiazide—Dermatitis—Doxorubicin—bone cancer	0.00265	0.00265	CcSEcCtD
Methyclothiazide—Headache—Doxorubicin—bone cancer	0.00264	0.00264	CcSEcCtD
Methyclothiazide—Nausea—Doxorubicin—bone cancer	0.0025	0.0025	CcSEcCtD
